IGFBP1
Insulin-like growth factor-binding protein 1
Also known as: AFBP, hIGFBP-1, IBP1, IBP1_HUMAN, IGF-BP25, PP12
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P08833
- Gene
- IGFBP1
- Ensembl
- ENSG00000146678
- Chromosome
- 7
- Canonical length
- 259 aa
- Protein class
- Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins
- Subcellular location
- Golgi apparatus
- Secretome location
- Secreted to blood
OverviewNCBI Gene
This gene is a member of the insulin-like growth factor binding protein (IGFBP) family and encodes a protein with an IGFBP N-terminal domain and a thyroglobulin type-I domain. The encoded protein, mainly expressed in the liver, circulates in the plasma and binds both insulin-like growth factors (IGFs) I and II, prolonging their half-lives and altering their interaction with cell surface receptors. This protein is important in cell migration and metabolism. Low levels of this protein may be associated with impaired glucose tolerance, vascular disease and hypertension in human patients. [provided by RefSeq, Aug 2017]
Canonical amino-acid sequenceUniProt
259 residues, UniProt reviewed canonical sequence.
>P08833|IGFBP1
1 MSEVPVARVW LVLLLLTVQV GVTAGAPWQC APCSAEKLAL CPPVSASCSE VTRSAGCGCC
61 PMCALPLGAA CGVATARCAR GLSCRALPGE QQPLHALTRG QGACVQESDA SAPHAAEAGS
121 PESPESTEIT EEELLDNFHL MAPSEEDHSI LWDAISTYDG SKALHVTNIK KWKEPCRIEL
181 YRVVESLAKA QETSGEEISK FYLPNCNKNG FYHSRQCETS MDGEAGLCWC VYPWNGKRIP
241 GSPEIRGDPN CQIYFNVQNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IGFBP1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.44
- Highest tissue expression
- 1,121 nTPM
Expression across tissuesHPA
Tissue
- liver: 1,121 nTPM
- placenta: 192 nTPM
- endometrium: 75 nTPM
- ovary: 46 nTPM
- fallopian tube: 3.8 nTPM
- adipose tissue: 2.7 nTPM
Single-cell type
- hepatocytes: 1,210 nCPM
- decidual stromal cells: 1,197 nCPM
- endometrial stromal cells: 69 nCPM
- fallopian tube ciliated cells: 43 nCPM
- cholangiocytes: 28 nCPM
- myosatellite cells: 23 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- pons: 2 nTPM
- medulla oblongata: 1.4 nTPM
- cerebral cortex: 0.7 nTPM
- hypothalamus: 0.7 nTPM
- midbrain: 0.7 nTPM
- thalamus: 0.7 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.19
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.25
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- insulin receptor signaling pathway
- negative regulation of canonical Wnt signaling pathway
- positive regulation of cell growth
- regulation of insulin-like growth factor receptor signaling pathway
- signal transduction
- tissue regeneration
Molecular functions
- insulin-like growth factor binding
- insulin-like growth factor I binding
- insulin-like growth factor II binding
- signaling receptor binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Thyroglobulin type-1
- Insulin-like growth factor-binding protein, IGFBP
- Growth factor receptor cysteine-rich domain superfamily
- Insulin-like growth factor binding protein, N-terminal, Cys-rich conserved site
- Insulin-like growth factor-binding protein family 1-6, chordata
- Thyroglobulin type-1 superfamily
- Thyroglobulin type-1 repeat
- Insulin-like growth factor binding protein
- Insulin-like growth factor-binding protein 1
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of IGFBP1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IGFBP1 as an antibody target. Whether an autoantibody or antibody against IGFBP1 could matter depends on whether native IGFBP1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IGFBP1 is annotated as secreted, so native IGFBP1 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label IGFBP1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...